Loading stock data…
Philip Morris International Inc (PM)
$182.53-3.64 (-1.96%)
Pre-Market$181.85-0.68 (-0.37%)· Last close Sep 4
Philip Morris International Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Philip Morris International Inc. in the Consumer Defensive sector is trading at $182.53 with a market capitalization of $288.9B. Wall Street consensus targets $207.13 (15 analysts), implying a +13.5% move over the next 12 months. The stock is currently 12% below its 52-week high of $207.76, remaining 5.8% above its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality, Altman Z in the safe zone. The Whystock Score of 100/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +13.5% upside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $11.19B↑ | $10.15B↓ | $10.36B↓ | $10.85B↑ | $10.14B |
| Gross Profit | $7.66B↑ | $6.91B↑ | $6.80B↓ | $7.36B↑ | $6.87B |
| Operating Income | $4.53B↑ | $3.89B↑ | $3.37B↓ | $4.26B↑ | $3.75B |
| Net Income | $2.82B↑ | $2.44B↑ | $2.14B↓ | $3.48B↑ | $3.04B |
Peer Comparison
Fundamentals
Philip Morris International Inc. operates as a tobacco company. The company offers cigarettes and smoke-free products, including heat-not-burn, e-vapor, and oral nicotine products under the IQOS, VEEV, and ZYN brands; and consumer accessories, such a...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$288.92B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
25.46
Beta
Defensive asset. Lower volatility than the S&P 500.
0.40
Div Yield
Strong income play. Yield provides a meaningful total return floor.
3.22%
ROE
Average efficiency. Growth may require heavy reinvestment.
-126.69%
Volume
Today's trading volume
3.13M
Recent News
FDA Authorization Expands Philip Morris’s Zyn Bet, Can It Pay Off?
Philip Morris International Inc. (NYSE:PM) has received FDA authorization for 11 nicotine-pouch products, bolstering its position in the fastest-growing nicotine category in the United States. The newly authorized products include higher-strength Zyn Ultra pouches that Philip Morris (NYSE:PM) launched in June at prices below those of its flagship Zyn brand. The strategy could help the […]
No ETFs Required: How a 64-Year-Old Built a $5,700 Monthly Paycheck From Five Dividend Stocks
Most retirees assume hitting a $68,400 annual income floor demands either a massive nest egg or risky high-yield instruments, but five ordinary dividend stocks across five sectors challenge both assumptions in ways the math makes hard to ignore.
I've Been Wrong About Philip Morris International Stock for 5 Years. Here's Why I'm Finally Changing My Mind.
Philip Morris has transformed from a declining tobacco play into a higher-margin, smoke-free growth story. Here's why I'm changing my mind on PM.
Is Altria's on! PLUS Shaping Up as Its Next Major Growth Engine?
MO's on! PLUS is gaining retail share and nationwide reach, with new strengths and flavors set to broaden its nicotine pouch lineup in 2026.
Philip Morris Stock: Is PM Outperforming the Consumer Staples Sector?
Philip Morris has surpassed the broader consumer staples sector over the past year, and analysts remain moderately optimistic about the stock’s prospects.